Tumor blood flow from arterial spin labeling perfusion MRI: A key parameter in distinguishing high‐grade gliomas from primary cerebral lymphomas, and in predicting genetic biomarkers in high‐grade gliomas

To evaluate the usefulness of pseudo‐continuous arterial spin labeling (pCASL) imaging in differentiating high‐grade gliomas from lymphomas and in noninvasively predicting genetic biomarkers in high‐grade gliomas.

[1]  G. Sauter,et al.  Lessons learnt from gefitinib and erlotinib: Key insights into small-molecule EGFR-targeted kinase inhibitors in non-small cell lung cancer. , 2010, Lung cancer.

[2]  Scar,et al.  Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. , 2000, The New England journal of medicine.

[3]  V. Tronnier,et al.  Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging , 2003, Neuroscience Letters.

[4]  J. Pauly,et al.  Background suppression with multiple inversion recovery nulling: Applications to projective angiography , 1997, Magnetic resonance in medicine.

[5]  Goldman,et al.  Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. , 1993, Molecular biology of the cell.

[6]  N. Chen,et al.  Apoptosis and Proliferation Markers in Diffusely Infiltrating Astrocytomas: Profiling of 17 Molecules , 2006, Journal of neuropathology and experimental neurology.

[7]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[8]  K. Hoang-Xuan,et al.  Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas. , 2008, Neuro-oncology.

[9]  James H Thrall,et al.  Biomarkers in imaging: realizing radiology's future. , 2003, Radiology.

[10]  A. Koong,et al.  Loss of PTEN facilitates HIF-1-mediated gene expression. , 2000, Genes & development.

[11]  V. Tronnier,et al.  Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas , 2010, European Radiology.

[12]  H. Kauczor,et al.  Assessment of Irradiated Brain Metastases by Means of Arterial Spin-Labeling and Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MRI: Initial Results , 2004, Investigative radiology.

[13]  G. Semenza,et al.  Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. , 2000, Cancer research.

[14]  Iris Asllani,et al.  Arterial Spin Labeling (ASL) fMRI: Advantages, Theoretical Constrains and Experimental Challenges in Neurosciences , 2012, Int. J. Biomed. Imaging.

[15]  Amit Maity,et al.  PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter. , 2003, Cancer research.

[16]  E. Neuwelt,et al.  MR of primary CNS lymphoma in immunologically normal patients. , 1992, AJNR. American journal of neuroradiology.

[17]  Sylvia Drabycz,et al.  An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging , 2010, NeuroImage.

[18]  Bahattin Hakyemez,et al.  Evaluation of different cerebral mass lesions by perfusion‐weighted MR imaging , 2006, Journal of magnetic resonance imaging : JMRI.

[19]  J. Guyotat,et al.  Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors , 2006, Neuroradiology.

[20]  F. Schick,et al.  Autoimmune thyroid disease: arterial spin-labeling perfusion MR imaging. , 2009, Radiology.

[21]  M. Bronskill,et al.  T1, T2 relaxation and magnetization transfer in tissue at 3T , 2005, Magnetic resonance in medicine.

[22]  J. Detre,et al.  Grading of CNS neoplasms using continuous arterial spin labeled perfusion MR imaging at 3 Tesla , 2005, Journal of magnetic resonance imaging : JMRI.

[23]  K. Makino,et al.  Molecular and clinical analysis of glioblastoma with an oligodendroglial component (GBMO) , 2011, Brain Tumor Pathology.

[24]  Iris Asllani,et al.  Erratum to “Arterial Spin Labeling (ASL) fMRI: Advantages, Theoretical Constrains and Experimental Challenges in Neurosciences” , 2012, Int. J. Biomed. Imaging.

[25]  H. Itoh,et al.  Perfusion imaging of meningioma by using continuous arterial spin-labeling: comparison with dynamic susceptibility-weighted contrast-enhanced MR images and histopathologic features. , 2006, AJNR. American journal of neuroradiology.

[26]  D. O’Rourke,et al.  Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia. , 2000, Cancer research.

[27]  A. Maity,et al.  Cellular responses to EGFR inhibitors and their relevance to cancer therapy. , 2007, Cancer letters.

[28]  D. Alsop,et al.  Continuous flow‐driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields , 2008, Magnetic resonance in medicine.

[29]  K. Aldape,et al.  Identification of noninvasive imaging surrogates for brain tumor gene-expression modules , 2008, Proceedings of the National Academy of Sciences.

[30]  Donald S. Williams,et al.  Perfusion imaging , 1992, Magnetic resonance in medicine.

[31]  H. Kim,et al.  Differentiation among Glioblastoma Multiforme, Solitary Metastatic Tumor, and Lymphoma Using Whole-Tumor Histogram Analysis of the Normalized Cerebral Blood Volume in Enhancing and Perienhancing Lesions , 2010, American Journal of Neuroradiology.

[32]  R. Mirimanoff,et al.  MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.

[33]  C. Zimmer,et al.  Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. , 2003, Radiology.

[34]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[35]  C. Calli,et al.  Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. , 2006, European journal of radiology.

[36]  T Sasaki,et al.  Perfusion Imaging of Brain Tumors Using Arterial Spin-Labeling: Correlation with Histopathologic Vascular Density , 2008, American Journal of Neuroradiology.

[37]  Filip Lardon,et al.  A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. , 2010, The oncologist.

[38]  M. Gado,et al.  Projection angiograms of blood labeled by adiabatic fast passage , 1986, Magnetic resonance in medicine.

[39]  K. Hoang-Xuan,et al.  Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients , 2002, European Radiology.